158 related articles for article (PubMed ID: 31562867)
1. TRIB3 promotes lung cancer progression by activating β-catenin signaling.
Zhang X; Zhong N; Li X; Chen MB
Eur J Pharmacol; 2019 Nov; 863():172697. PubMed ID: 31562867
[TBL] [Abstract][Full Text] [Related]
2. TRIB3 confers glioma cell stemness via interacting with β-catenin.
Lu Y; Li L; Chen L; Gao Y; Chen X; Cao Y
Environ Toxicol; 2020 Jun; 35(6):697-706. PubMed ID: 31995275
[TBL] [Abstract][Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
Liu C; Zhang W; Wang J; Si T; Xing W
Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482
[TBL] [Abstract][Full Text] [Related]
5. m
Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
[TBL] [Abstract][Full Text] [Related]
6. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
[TBL] [Abstract][Full Text] [Related]
7. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
8. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
9. TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance.
Lin J; Zhang W; Niu LT; Zhu YM; Weng XQ; Sheng Y; Zhu J; Xu J
Clin Cancer Res; 2019 Oct; 25(20):6228-6242. PubMed ID: 31235507
[TBL] [Abstract][Full Text] [Related]
10. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.
Qian H; Chen L; Huang J; Wang X; Ma S; Cui F; Luo L; Ling L; Luo K; Zheng G
J Mol Med (Berl); 2018 Aug; 96(8):753-764. PubMed ID: 29872866
[TBL] [Abstract][Full Text] [Related]
12. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
13. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
14. Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer.
Zhou W; Ma J; Meng L; Liu D; Chen J
BMC Cancer; 2022 Apr; 22(1):459. PubMed ID: 35473511
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis.
Lei L; Wang Y; Zheng YW; Fei LR; Shen HY; Li ZH; Huang WJ; Yu JH; Xu HT
Curr Cancer Drug Targets; 2019; 19(8):674-680. PubMed ID: 30451112
[TBL] [Abstract][Full Text] [Related]
17. TRIB3 inhibits proliferation and promotes osteogenesis in hBMSCs by regulating the ERK1/2 signaling pathway.
Zhang C; Hong FF; Wang CC; Li L; Chen JL; Liu F; Quan RF; Wang JF
Sci Rep; 2017 Sep; 7(1):10342. PubMed ID: 28871113
[TBL] [Abstract][Full Text] [Related]
18. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
[TBL] [Abstract][Full Text] [Related]
19. TRIB3 facilitates glioblastoma progression via restraining autophagy.
Tang Z; Chen H; Zhong D; Wei W; Liu L; Duan Q; Han B; Li G
Aging (Albany NY); 2020 Nov; 12(24):25020-25034. PubMed ID: 33203798
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
Bao XY; Sun M; Peng TT; Han DM
Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
